Study details
Enrolling now
Haploidentical Transplant Trial
University of Wisconsin, Madison
NCT IDNCT02508038ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
22
Study length
about 12 years
Ages
0.583333333333333–21
Locations
1 site in WI
What this study is about
This trial is testing the safety of a transplant using stem cells from a partially matched donor, combined with Zoledronate medication, in children with certain cancers. The goal is to see if this treatment helps patients who have relapsed or become resistant to other treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Zoledronate
- 2.Undergo TCRαβ+/CD19+ depleted Haploidentical HSCT
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology